Corticosteroids methylprednisolone

Parenteral corticosteroids Methylprednisolone Depo-Medrol Solu-Medrol Intramuscular Intravenous... 

CORTICOSTEROIDS CALCIUM CHANNEL BLOCKERS 1. Antihypertensive effect of calcium channel blockers are antagonized by corticosteroids 2. t adrenal suppressive effects of corticosteroids, methylprednisolone and prednisolone when co-admin-istered with diltiazem, nifedipine and verapamil. This may t risk of infections and produce an inadequate response to stress scenarios 1. Mineralocorticoids cause sodium and water retention, which antagonizes the hypotensive effects of calcium channel blockers 2. Due to inhibition of metabolism of these corticosteroids 1. Monitor BP at least weekly until stable 2. Monitor cortisol levels and warn patients to report symptoms such as fever and sore throat... 

A method for the determination of the corticosteroid methylprednisolone acetate in solutions... 

Patients with severe UC symptoms require hospitalization for management of their disease. If the patient is unresponsive to oral or topical mesalamine and oral corticosteroids, then a course of intravenous corticosteroids should be initiated.1 Hydrocortisone 300 mg/day given in three divided doses or methylprednisolone 60 mg daily for 7 to 10 days are the preferred therapies. 

Budesonide 9 mg orally once daily for up to 8 weeks may be used for mild to moderate active CD in patients with involvement of the terminal ileum or ascending colon, with success expected in 50% to 60% of patients.23 Because the formulation releases budesonide in the terminal ileum, it is not effective in reaching sites distal to the ascending colon.23,36 Conventional oral corticosteroids such as prednisone and methylprednisolone may be used for patients who are unresponsive to aminosalicylates or budesonide. 

In rare instances (0.5% to 2% of pregnancies), NVP progresses to hyperemesis gravidarum.9 Treatment may require the use of enteral or parenteral nutrition if weight loss is present. A corticosteroid such as methylprednisolone may be considered. Methylprednisolone is associated with oral clefts in the fetus when used during the first trimester therefore, corticosteroids should be reserved as a last resort and should be avoided during the first 10 weeks of gestation.9,11... 

Corticosteroids hasten functional recovery after relapses.27 Intravenous adrenocorticotropic hormone, intravenous methylprednisolone, or oral prednisone are used for treatment of relapses. Generally, intravenous methylprednisolone is considered the drug of choice for acute relapses.28... 

Clinical improvement usually begins during corticosteroid treatment. No standard exists for the administration of an oral prednisone taper after the intravenous methylprednisolone treatment. If a taper is given, it is usually completed over 1 to 2 weeks. 

The most commonly used corticosteroids are methylpred-nisolone (IV and oral) and prednisone (oral), although prednisolone and dexamethasone also have been shown to be effective for organ transplantation. Corticosteroid doses vary by center-specific protocols, organ type, and patient characteristics. A typical taper would include an IV 100 to 500 mg bolus of methylprednisolone at the time of transplant and then a taper over 5 to 7 days to a maintenance dose of prednisone 20 mg/day or complete cessation.2,7 It is important for practitioners to know that approximately 4 mg methylprednisolone is equivalent to 5 mg prednisone and 0.75 mg dexamethasone.11 At most transplant centers, therapeutic drug monitoring of corticosteroids is not employed. Corticosteroids are associated with a variety of acute and chronic toxicides. The most common adverse events have been summarized in Table 52-5. 

A first open, uncontrolled study [46], performed in 12 patients with active IBD refractory to standard treatment who all had positive stool culture, suggested that adding rifaximin (800 mg daily) could be beneficial. A further small but controlled investigation performed in our unit [47] evaluated the efficacy and systemic absorption of rifaximin in patients with moderately to severely active UC refractory to steroid treatment. Patients were eligible if they had no response to intravenous corticosteroid therapy (methylprednisolone 1 mg/kg/day) after 7-10 days. Twenty-eight patients were randomized to receive rifaximin 400 mg b.i.d. or placebo for 10 days as an add-on... 

The methylprednisolone suleptanate 208b, the water-soluble prodrug of the methylprednisolone corticosteroid 208a, has been labelled with 14C exclusively at the carboxamide carbon175 which was found to be metabolically stable with no loss of 14CC>2 after administration to test animals and man. 

A single intramuscular injection of a long-acting corticosteroid (e.g., methylprednisolone acetate) can be used as an alternative to the oral route if patients are unable to take oral therapy. If not contraindicated, low-dose colchicine can be used as adjunctive therapy to injectable corticosteroids to prevent rebound flare-ups. 

Intraarticular corticosteroid injections can provide relief, particularly when a joint effusion is present. Average doses for injection of large joints in adults are methylprednisolone acetate 20 to 40 mg or triamcinolone hexacetonide 10 to 20 mg. After aseptic aspiration of the effusion and corticosteroid injection, initial pain relief may occur within 24 to 72 hours, with peak relief occurring in about 1 week and lasting for 4 to 8 weeks. The patient should minimize joint activity and stress on the joint for several days after the injection. Therapy is generally limited to three or four injections per year because of the potential systemic effects of the drugs and because the need for more frequent injections indicates poor response to therapy. 

Oral corticosteroids (e.g., prednisone, methylprednisolone) can be used to control pain and synovitis while DMARDs are taking effect ( bridging therapy ). This is often used in patients with debilitating symptoms when DMARD therapy is initiated. 

Hydrocortisone is available orally. Other corticosteroids also available orally include prednisolone, betamethasone, cortisone acetate, methylprednisolone, dexamethasone and fluocortolone. 

Corticosteroids, weak (group I) hydrocortisone hydrocortisone acetate methylprednisolone... 

Urgent treatment is often begun with an oral dose of 30-60 mg prednisone per day or an intravenous dose of 1 mg/kg methylprednisolone every 6 hours the daily dose is decreased after airway obstruction has improved. In most patients, systemic corticosteroid therapy can be discontinued in a week or 10 days, but in other patients symptoms may worsen as the dose is decreased to lower levels. Because adrenal suppression by corticosteroids is related to dose and because secretion of endogenous corticosteroids has a diurnal variation, it is customary to administer corticosteroids early in the morning after endogenous ACTH secretion has peaked. For prevention of nocturnal asthma, however, oral or inhaled corticosteroids are most effective when given in the late afternoon. 

A generic enzyme immunoassay for the determination of several synthetic corticosteroids including dexamethasone, betamethasone, flumethasone, triamcinolone, prednisolone, and methylprednisolone in milk, liver, kidney, and muscle samples was recently developed (156). Antibodies raised against dexamethasone-21-hemisuccinate-bovine serum albumin were used in this assay, whereas dexa-methasone-horseradish peroxidase was the label conjugate. Skimmed milk could be directly screened for the presence of corticosteroids at limits of detection of 0.1 ppb for dexamethasone, betamethasone, and flumethasone, 0.3 ppb for triamcinolone and 0.5 ppb for prednisolone. Tissue samples were submitted, prior to the immunoassay, to an extraction/cleanup procedure involving liquid-liquid partitions with acetonitrile-water followed by hexane-chloroform. Background values for bovine liver, swine kidney, and calf muscle were determined to be 0.26, 0.26, and 0.07 ppb, respectively, of dexamethasone equivalents. 

Fig. 29.17 TIC and SIR recordings collected from blank and spiked milk samples with 2 ppb of the various tested corticosteroids. From top to bottom total ionic current m/z 313, tp 17 97/18 13 min for dexamethasone (IS) m/z 310, tp 17 99/18 14 min for dexamethasone m/z 328, tp 17 86/18 01 min for flumethasone m/z 298, tp 18 34 min for prednisolone m/z 312, tp 18 73 min for methylprednisolone m/z 296, tp 17 97 min for isoflupredone. (Reprinted from Ref. 527, with permission from Elsevier Science.)...

Methylprednisolone Succinate and Acetate (Solu-Medrol, Depo-Medrol) [Steroid] Uses Tx inflammation d/t anaphylaxis and asthma suspected SCI Action Adrenal corticosteroid Dose Adults. Anaphylaxis/ status asthmaticus 125-250 mg IV/IM Suspected SCI Load w/ 30 mg/kg then inf... 

Banik, N.L., Matzelle, D., Terry, E., Hogan, E.L., 1997, A new mechanism of methylprednisolone and other corticosteroids action demonstrated in vitro inhibition of a proteinase (calpain) prevents myelin and cytoskeletal protein degradation, Brain. Res. 748,205—210... 

Corticosteroids (dexamethasone, methylprednisolone) have antiemetic properties, but the basis for these effects is unknown. These agents are commonly used in combination with other agents in the... 

Inflammatory response after stent implantation plays an important role in the cascade of neointimal formation. A positive correlation between inflammatory reaction and restenosis has been observed (16). Perivasculitis caused by stent deployment also participates in the neointimal formation (17). Corticosteroids, as an anti-inflammatory agent, have been evaluated. Methylprednisolone (MP)-loaded stents with different doses showed a positive dose-related effect on neointimal hyperplasia (18). Furthermore, MP-coated stents showed decreased macrophages at the stented sites (19). In clinic, dexamethasone-coated stents showed an inhibitive effect on neointimal hyperplasia in selected patients (20), although no beneficial effect was observed in a randomized trial compared to bare stents (21). For other type of drugs with anti-inflammatory characteristics, such as ibuprofen, colchicine, aton/astatin, and probucol, no favorable effects on neointimal hyperplasia were observed (18,22,23). 

Correct answer = C. An acute asthmatic crisis often requires IV corticosteroids, often methylprednisolone. Inhaled beclomethasone will not deliver enough steroid to fully combat airway inflammation. 

Corticosteroids Dexamethasone and methylprednisolone used alone are effective against mildly to moderately emetogenic chemotherapy. Their antiemetic mechanism is not known, but may involve blockade of prostaglandins. These drugs can cause insomnia and hyperglycemia in patients with diabetes mellitus. 

Figure 10 CEC-UV chromatogram (240 nm) of a mixture of 10 corticosteroids (100 qg/mL) using a linear gradient elution program. Voltage = 30 kV, HPLC injection volume = 10 pL, flow-rate = 10 pL/min for 3 min, then decreased to 100 pL/ min. Gradient program = initial ammonium acetate, 5 mM, in acetonitrile/water (17/83), held for 3 min, then ramped to 38% acetonitrile at 15 min and maintained to end of run. Column = Hypersil ODS, 3 pm, 42 cm total length, 30 cm packed length, 30.1 cm to window, 1 = triamcinolone, 2 = hydrocortisone and prednisolone co-eluting, 3 = cortisone, 4 = methylprednisolone, 5 = betamethasone, 6 = dexamethasone, 7 = adrenosterone, 8 = fluocortolone, 9 = triamcinolone aceto-nide. (Reprinted from Ref. 57, with permission.)...

---